Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet

Journal of Hepatology

Volumn 41, Issue 4, 2004, Pages 592-598

  Koppe, Sean W P ^a   Sahai, Atul ^b   Malladi, Padmini ^b   Whitington, Peter F ^b   Green, Richard M ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Chicago IL 60611 U ^*  (United States)

Author keywords

Methionine choline deficient (MCD) diet; Oxidative stress; Pentoxifylline; Steatohepatitis; TNF alpha

Indexed keywords

ALANINE AMINOTRANSFERASE; BILE SALT; CHOLINE DERIVATIVE; GLUTATHIONE; LIPID; MESSENGER RNA; METHIONINE DERIVATIVE; PENTOXIFYLLINE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FATTY LIVER; FEMALE; HISTOLOGY; LIPID BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALANINE TRANSAMINASE; ANIMALS; CHOLINE DEFICIENCY; DEFICIENCY DISEASES; DIET; DISEASE PROGRESSION; FATTY LIVER; FEMALE; GLUTATHIONE; HEPATITIS; LIVER; MALE; METHIONINE; MICE; MICE, INBRED C57BL; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; RNA, MESSENGER; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4644224457     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.06.030     Document Type: Article

References (50)

1. C.A. Matteoni, Z.M. Younossi, T. Gramlich, N. Boparai, Y.C. Liu, and A.J. McCullough Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419
2. S.H. Caldwell, D.H. Oelsner, J.C. Iezzoni, E.E. Hespenheide, E.H. Battle, and C.J. Driscoll Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 29 1999 664 669
3. R.M. Green NASH-hepatic metabolism and not simply the metabolic syndrome Hepatology 38 2003 14 17
4. S.Q. Yang, H.Z. Lin, M.D. Lane, M. Clemens, and A.M. Diehl Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis Proc Natl Acad Sci USA 94 1997 2557 2562
5. N. Enomoto, K. Ikejima, B. Bradford, C. Rivera, H. Kono, D.A. Brenner, and R.G. Thurman Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin Gastroenterology 115 1998 443 451
6. G.L. Su Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation Am J Physiol Gastrointest Liver Physiol 283 2002 G256 G265
7. J.B. Hoek, and J.G. Pastorino Ethanol, oxidative stress, and cytokine-induced liver cell injury Alcohol 27 2002 63 68
8. S. Chitturi, and G.C. Farrell Etiopathogenesis of nonalcoholic steatohepatitis Semin Liver Dis 21 2001 27 41
9. A. Khoruts, L. Stahnke, C.J. McClain, G. Logan, and J.I. Allen Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients Hepatology 13 1991 267 276
10. M. Yin, M.D. Wheeler, H. Kono, B.U. Bradford, R.M. Gallucci, and M.I. Luster Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice Gastroenterology 117 1999 942 952
11. C.J. McClain, D. Hill, J. Schmidt, and A.M. Diehl Cytokines and alcoholic liver disease Semin Liver Dis 13 1993 170 182
12. J. Crespo, A. Cayon, P. Fernandez-Gil, M. Hernandez-Guerra, M. Mayorga, and A. Dominguez-Diez Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients Hepatology 34 2001 1158 1163
13. M. Kugelmas, D.B. Hill, B. Vivian, L. Marsano, and C.J. McClain Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E Hepatology 38 2003 413 419
14. Y. Iimuro, R.M. Gallucci, M.I. Luster, H. Kono, and R.G. Thurman Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat Hepatology 26 1997 1530 1537
15. Z. Li, S. Yang, H. Lin, J. Huang, P.A. Watkins, and A.B. Moser Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease Hepatology 37 2003 343 350
16. A. Koteish, and A.M. Diehl Animal models of steatosis Semin Liver Dis 21 2001 89 104
17. I.A. Leclercq, G.C. Farrell, J. Field, D.R. Bell, F.J. Gonzalez, and G.R. Robertson CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis J Clin Invest 105 2000 1067 1075
18. R.K. Chawla, W.H. Watson, C.E. Eastin, E.Y. Lee, J. Schmidt, and C.J. McClain S-adenosylmethionine deficiency and TNF-alpha in lipopolysaccharide- induced hepatic injury Am J Physiol 275 1998 G125 G129
19. J. George, N. Pera, N. Phung, I. Leclercq, J. Yun Hou, and G. Farrell Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis J Hepatol 39 2003 756 764
20. R.M. Strieter, D.G. Remick, P.A. Ward, R.N. Spengler, J.P. Lynch 3rd, and J. Larrick Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline Biochem Biophys Res Commun 155 1988 1230 1236
21. M. Leist, S. Auer-Barth, and A. Wendel Tumor necrosis factor production in the perfused mouse liver and its pharmacological modulation by methylxanthines J Pharmacol Exp Ther 276 1996 968 976
22. C. Dominguez-Jimenez, D. Sancho, M. Nieto, M.C. Montoya, O. Barreiro, and F. Sanchez-Madrid Effect of pentoxifylline on polarization and migration of human leukocytes J Leukoc Biol 71 2002 588 596
23. R. Gonzalez-Amaro, D. Portales-Perez, L. Baranda, J.M. Redondo, S. Martinez-Martinez, and M. Yanez-Mo Pentoxifylline inhibits adhesion and activation of human T lymphocytes J Immunol 161 1998 65 72
24. S. Dunzendorfer, P. Schratzberger, N. Reinisch, C.M. Kahler, and C.J. Wiedermann Pentoxifylline differentially regulates migration and respiratory burst activity of the neutrophil Ann N Y Acad Sci 832 1997 330 340
25. V.B. Bhat, and K.M. Madayastha Antioxidant and radical scavenging properties of 8-oxo derivatives of xanthine drugs pentoxifylline and lisofylline Biochem Biophys Res Commun 288 2001 1212 1217
26. J.P. Freitas, and P.M. Filipe Pentoxifylline. A hydroxyl radical scavenger Biol Trace Elem Res 47 1995 307 311
27. S.M. Crouch, and J. Fletcher Effect of ingested pentoxifylline on neutrophil superoxide anion production Infect Immun 60 1992 4504 4509
28. L. Gomez-Cambronero, B. Camps, J.G. de La Asuncion, M. Cerda, A. Pellin, and F.V. Pallardo Pentoxifylline ameliorates cerulein-induced pancreatitis in rats: role of glutathione and nitric oxide J Pharmacol Exp Ther 293 2000 670 676
29. E. Akriviadis, R. Botla, W. Briggs, S. Han, T. Reynolds, and O. Shakil Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial Gastroenterology 119 2000 1637 1648
30. E. Hernandez, A. Correa, and L. Bucio Pentoxifylline diminished acetaldehyde-induced collagen production in hepatic stellate cells by decreasing interleukin-6 expression Pharmacol Res 46 2002 435 443
31. A.M. Preaux, A. Mallat, J. Rosenbaum, E.S. Zafrani, and P. Mavier Pentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast-like cells Hepatology 26 1997 315 322
32. R.G. Romanelli, A. Caligiuri, V. Carloni, R. DeFranco, P. Montalto, and E. Ceni Effect of pentoxifylline on the degradation of procollagen type I produced by human hepatic stellate cells in response to transforming growth factor-beta 1 Br J Pharmacol 122 1997 1047 1054
33. C. Raetsch, J.D. Jia, G. Boigk, M. Bauer, E.G. Hahn, and E.O. Riecken Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis Gut 50 2002 241 247
34. A. Desmouliere, G. Xu, A.M. Costa, I.M. Yousef, G. Gabbiani, and B. Tuchweber Effect of pentoxifylline on early proliferation and phenotypic modulation of fibrogenic cells in two rat models of liver fibrosis and on cultured hepatic stellate cells J Hepatol 30 1999 621 631
35. F. Oberti, C. Pilette, H. Rifflet, M.Y. Maiga, A. Moreau, and Y. Gallois Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation J Hepatol 26 1997 1363 1371
36. T.C. Peterson, and M. Neumeister Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism Immunopharmacology 31 1996 183 193
37. Z.M. Yao, and D.E. Vance Reduction in VLDL, but not HDL, in plasma of rats deficient in choline Biochem Cell Biol 68 1990 552 558
38. O.G. Bjornsson, J.D. Sparks, C.E. Sparks, and G.F. Gibbons Regulation of VLDL secretion in primary culture of rat hepatocytes: involvement of cAMP and cAMP-dependent protein kinases Eur J Clin Invest 24 1994 137 148
39. P.D. Thompson, R. Zimet, W.P. Forbes, and P. Zhang Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication Am J Cardiol 90 2002 1314 1319
40. M.B. Elam, J. Heckman, J.R. Crouse, D.B. Hunninghake, J.A. Herd, and M. Davidson Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication Arterioscler Thromb Vasc Biol 18 1998 1942 1947
41. T. Hirose, S. Kurebayashi, and S. Kasayama Antiplatelet agent cilostazol potentiates adipocyte differentiation of 3T3-L1 cells Atherosclerosis 158 2001 19 22
42. T. Tani, K. Uehara, T. Sudo, K. Marukawa, Y. Yasuda, and Y. Kimura Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats Atherosclerosis 152 2000 299 305
43. M.R. Clemens, and M. Ruess Effect of pentoxifylline on erythrocyte membrane and plasma lipids Eur J Clin Pharmacol 41 1991 623 624
44. E.M. Brunt Nonalcoholic steatohepatitis: definition and pathology Semin Liver Dis 21 2001 3 16
45. H. Trentzsch, D. Stewart, and A. De Maio Genetic background conditions the effect of sex steroids on the inflammatory response during endotoxic shock Crit Care Med 31 2003 232 236
46. E. Schwarz, C. Schafer, J.C. Bode, and C. Bode Influence of the menstrual cycle on the LPS-induced cytokine response of monocytes Cytokine 12 2000 413 416
47. D. Verthely, and D.M. Klinman Sex hormone levels correlate with the activity of cytokine-secreting cells in vivo Immunology 100 2000 384 390
48. A.A. Nanji, K. Jokelainen, M. Fotouhinia, A. Rahemtulla, P. Thomas, and G.L. Tipoe Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines Am J Physiol Gastrointest Liver Physiol 281 2001 G1348 G1356
49. H. Kono, M.D. Wheeler, I. Rusyn, M. Lin, V. Seabra, and C.A. Rivera Gender differences in early alcohol-induced liver injury: role of CD14, NF-kappaB, and TNF-alpha Am J Physiol Gastrointest Liver Physiol 278 2000 G652 G661
50. L.A. Adams, C.O. Zein, K.D. Lindor, and P. Angulo A pilot trial of pentoxifylline in non-alcoholoc steatohepatitis Gastroenterology 126S2 2004 A-757 (abstract)